SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,255
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/7/2017 7:32:14 AM
Compugen Reports Third Quarter 2017 Results "PR Newswire (US)" - 11/7/2017 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/6/2017 8:01:08 AM
Compugen to Initiate Manufacturing of COM902, its Lead Anti-TIGIT Monoclonal Antibody "PR Newswire (US)" - 11/6/2017 7:00:00 AM
Compugen to Enter Research Collaboration With Mount Sinai on Novel Myeloid Immuno-Oncology Targets "PR Newswire (US)" - 11/2/2017 7:00:00 AM
Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month "PR Newswire (US)" - 10/26/2017 7:00:00 AM
Compugen Third Quarter 2017 Conference Call Scheduled for Tuesday, November 7, 2017 at 10:00 AM ET "PR Newswire (US)" - 10/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/19/2017 9:41:56 AM
A New Immunomodulatory Target Discovered by Compugen Demonstrates Potential for First-in-Class Cancer Therapy "PR Newswire (US)" - 10/9/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/6/2017 7:10:35 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/14/2017 3:33:21 PM
Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month "PR Newswire (US)" - 8/7/2017 7:00:00 AM
Compugen Welcomes Paul Sekhri as its New Chairman of the Board "PR Newswire (US)" - 8/2/2017 7:22:00 AM
Compugen Reports Second Quarter 2017 Results "PR Newswire (US)" - 8/2/2017 7:20:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/2/2017 7:18:10 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/26/2017 7:31:02 AM
Compugen Discloses Updates to Collaborative Activities with Bayer in Immuno-Oncology "PR Newswire (US)" - 7/26/2017 7:09:00 AM
Compugen Announces Issuance of U.S. Patent for COM701, its Lead Immuno-Oncology Product Candidate "PR Newswire (US)" - 7/25/2017 7:00:00 AM
Compugen Second Quarter 2017 Conference Call Scheduled for Wednesday, August 2, 2017 at 10:00 AM ET "PR Newswire (US)" - 7/24/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/14/2017 10:38:05 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/13/2017 8:41:33 AM
Compugen Presents at ASCO COM701 Drug Combination Data with TIGIT and PD-1 Inhibitors in Preclinical Models "PR Newswire (US)" - 6/5/2017 9:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/31/2017 7:01:11 AM
Compugen Provides Update on COM701 and Upcoming Presentations "PR Newswire (US)" - 5/31/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/30/2017 6:21:35 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist